Infectious Neuropathies

@article{RobinsonPapp2012InfectiousN,
  title={Infectious Neuropathies},
  author={Jessica Robinson-Papp},
  journal={CONTINUUM: Lifelong Learning in Neurology},
  year={2012},
  volume={18},
  pages={126–138}
}
  • J. Robinson-Papp
  • Published 1 February 2012
  • Medicine, Biology
  • CONTINUUM: Lifelong Learning in Neurology
Purpose of Review: The purpose of this review is to address bacterial, viral, and other infectious causes of neuropathy or neuronopathy, with an emphasis on clinical manifestations and treatment. Recent Findings: Most infectious neuropathies have been well described for some time and treatments are well established. An exception is HIV-associated distal symmetric polyneuropathy, which is an area of active research. Current work in this area focuses on epidemiology, risk factors, and underlying… 
View on Wolters Kluwer
ncbi.nlm.nih.gov
1 Citations
Background Citations
1

Figures and Tables from this paper

One Citation

Guillain-Barré Syndrome and Human Immunodeficiency Virus Introduction

Guillain-Barré syndrome is an acute disease, which is characterized by symmetric muscle weakness, loss of sensation and loss of deep tendon reflexes and it is 1.5-2 times frequent in males compared to females.

References

SHOWING 1-10 OF 43 REFERENCES

Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.

  • D. SimpsonM. Tagliati
  • Medicine, Biology
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
  • 1995
The identification and treatment of peripheral neuropathies associated with use of the nucleoside drugs zalcitabine, didanosine (ddI), and stavudine (d4T) are reviewed.

Lyme disease and the peripheral nervous system

Lyme disease, the multisystem infectious disease caused by the tick‐borne spirochete Borrelia burgdorferi, causes a broad variety of peripheral nerve disorders, including single or multiple cranial…

HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease

HIV‐associated neuropathies have become the most frequent neurological disorder associated with HIV infection and the use of skin biopsy has become a useful tool in the evaluation of HIV‐N.

Neuromuscular diseases associated with HIV‐1 infection

The following HIV‐associated conditions are reviewed: distal symmetric polyneuropathy; inflammatory demyelinating polyne Neuropathy; mononeuropathy multiplex; autonomic neuropathy; progressive polyradiculopathy due to cytomegalovirus; herpes zoster; myopathy; and other, rarer disorders.

Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study

The multifocal necrotic endoneurial nerve lesions with polymorphonuclear cell infiltration the authors describe may help identify cytomegalovirus neuropathy when characteristic inclusions are not present in the biopsy specimen.

West Nile virus infection

An overlapping spectrum of meningitis, encephalitis, and myeloradiculitis occurs in CNS WNV infection, and fever, rash, abdominal and back pain, preceding a proximal, asymmetric flaccid weakness, with CSF pleocytosis help distinguish the motor syndrome from Guillain–Barré syndrome.

Update on medication-induced peripheral neuropathy

A progressive inflammatory neuropathy in swine slaughterhouse workers that appears to be a toxin-induced immune response is described and dichloroacetate is a promising agent for lactic acidosis-associated disorders, but toxic neuropathy is a treatment-limiting factor.

HIV neuropathy natural history cohort study

In this cohort of advanced HIV infection–infected subjects, distal sensory polyneuropathy was common and relatively stable over 48 weeks, and previously established risk factors, including CD4 cell count, plasma HIV RNA, and use of dideoxynucleoside antiretrovirals were not predictive of the progression of DSP.

Nerve damage in leprosy and its management

Evidence that clinical neuropathy represents only the 'tip of the iceberg' of nerve damage, together with an understanding that the underlying inflammatory immunological processes require longer, more-aggressive treatment, could help usher in new and more-successful approaches to the treatment of nerve-function impairment in leprosy.

Impairment of the peripheral nervous system in Creutzfeldt-Jakob disease.

In sporadic cases of CJD, peripheral nervous system impairment should be considered to be an integral component of disease.